Did CVS Resort to Tricks to Boost Its Earnings?

 

CVS (CVS), the drugstore chain, hasn't reported fourth-quarter earnings yet, but when it does on Feb. 8, some analysts will be looking extra closely at whether the company just meets or exceeds its forecast of 43 cents per share. The difference is crucial, considering that CVS quietly added a week to its December monthly sales reporting period. Rather than covering five weeks, which has been the case in December in prior years, the monthly data were boosted to six weeks. (Likewise, the year was stretched to 53 weeks from 52 weeks.)

What's more, the sales period ended Jan. 1, a day after CVS' fiscal year usually ends.

It's almost always a red flag when companies expand their sales reporting period because it suggests they're pulling out all the stops to goose the quarter. This year it's especially curious because the last week of the year was unusually strong for pharmacies, as people stocked up on prescriptions over Y2K fears.

CVS, though, says that isn't the case. A spokesman explained that, like other retailers, CVS typically has five weeks in the December quarter and that the quarter ends on the Saturday closest to Dec. 31. As a result, he says, every five years the company picks up six weeks.

Herb's Latest: Join the discussion on TSC Message Boards .

However (and this is an important one, folks, so stay with me), a look back at disclosures by CVS, which has only been a standalone company since 1996, shows that the sales period ended on Dec. 27 in 1997 and Dec. 26 in 1998. However, in each of those years, the closest Saturday to Dec. 31 was in January, and according to the company's own SEC filings, its fiscal year officially ends Dec. 31. (Confused? So am I.)

Why did CVS extend the reporting period into January this year, when Saturday days in January were closer than Saturdays in December last year and the year before? (Based on the prior years' schedule, this year's cutoff should've been Dec. 25!) A spokesman didn't know and couldn't find any execs to answer the question. (If they do, I'll forward those responses along in an "Extra" today.)

The extra week clearly caught some analysts by surprise, but the company says it shouldn't have because "all of our guidance throughout the year included the extra week." Maybe it did, but the company apparently didn't tell analysts. Merrill Lynch analyst Mark Husson, for example, wrote in a report to clients that the extra week was "unexpected." He couldn't be reached, but at least one person who knows Husson said he didn't know the year's guidance included an extra week.

Ditto Eric Bosshard of Midwest Research in Cleveland. "The first we heard of it was the day the sales were reported."

>To order reprints of this article, click here: Reprints

Herb Greenberg writes daily for TheStreet.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in TheStreet.com. He also doesn't invest in hedge funds or other private investment partnerships. He welcomes your feedback at herb@thestreet.com. Greenberg also writes a monthly column for Fortune.

Mark Martinez assisted with the reporting of this column.

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,890.46 1,351.95 2,927.23 20.47
Oil *
118.75
UP
6.51
UP
1.99
UP
11.37
UP
0.72
10 Yr
2.05%
SPDR Gold
168.02
+0.05%
+0.15%
+0.39%
+3.65%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet